and if the fda agrees that the original formulation was removed for safety reasons and the fda is precluded from approving generic competitors without comparable abuse-deterrent formulations. and in the absence of generic versions, then patients are forced to pay higher monopoly prices for extended time periods which in turn has the potential to decrease patient access to these drugs. um, have you heard about this? >> yes. and this is back to one of -- the discussion of the balances that are, you know, that need to be kept in mind as we think about addressing this abuse crisis. so in this case we have the necessary balance between incentivizing the development of abuse-deterrent formulations that work. we want to have opioids in formulations that deter abuse. that, i just believe that's everyone's best interest, to find a way to incentivize that while at the same time recognizing the impact and importance of the generics in the u.s. market. currently, well more than 75% of the total prescriptions, etc. accomplishing that balance is something that the fda's thinking and working very hard on.

we don't approve hope at the fda. >> reporter: until two years ago, dr.cote was the director of the fda's division for drugs that treat rare or so-called orphan diseases. the fda would not talk to us because the agency is not allowed to discuss any drug's application for approval. but dr. cote did agree to explain the policies in general. >> they want to see the real data. they don't want to hear your belief. they don't want to hear how you feel about the drugs. they want to see the facts. >> reporter: sometimes randomized clinical trials don't make sense. when do we put common sense and science in tandem? >> i think the common sense and science are in tandem already. >> reporter: what's more, dr. cote says, there is a way to get access to unapproved drugs. it's called compassionate use. and requires doctors to get special approval from the fda on behalf of their patients. >> that's exactly what compassionate use is for. is when you have a fatal disease and you have an opportunity and you think something might work. we're not having babies die because the

i guess the fda -- should the fda remove roadblocks to manufacturers who want to produce bruce deterchtdrugs so they can speed the new formula to market to reduce overall abuse? >> yes, we should. i view the technology and couraging their use in opioid as an incremental progress. process. we beginning to walk a road i hope to see a broad majority in abuse deterrent formulation. that's going depress your concern. the squeezing balloon. people moving from an abuse deterrent formulation to another formulation that is easier to abuse. in the short term, here i think we be fooling ourselves if we imagined it wasn't going happen. so my job, i think i guess our agency's job is incentivize the development of new technology broadly and to make certain those technologies demonstrate they work. so we should be developing abuse successfully reduce abuse through reviewing of the data, i believe the fda plays a critical role there. >> let me go to dr. clark. how can we educate health care providers to spot the warning signs. the warning signs of frequent fliers who might not have a legitimate need fo

with the fda, dr. clark thank you for coming.lease summarize your testimony. >> thank you chairman and for the opportunity to address the important issue of prescription drug abuse preventing it has been the goal of my office since my confirmation four years ago. along with a number of federal agencies are a government to redress the administration that recognizes it as a diseased that prevention and treatment of have to play a part of a comprehensive strategy to reduce drug use to give hope -- hope to those needed for public health and safety in we are here because the prescription drug abuse has had devastating consequences for safety in the country. increases for substance use disorders an emergency department visits and said they'd said deaths attributable to prescription drug overdose places the burden and over 2010 alone more than 22,000 overdose deaths were achievable to prescriptions with an almost 17,000 word to painkillers and in response to administration released a comprehensive program called prescription and drug ab

the fda has now tested about 300 samples. the agents still haven't identified any contaminants. inspectors found trace amounts of a type of antibiotic not approved in the u.s. that prompts two major makers to recall their treats. >> the trace amounts of antibiotic residue to not pose a health safety risk. the investigative unit found those and kingdom pets were among the brands with the most complaints between 2007 and 2012. on its web site, we hold our pruktss to the highest quality and standards are. kingdom pets posts results on its site. >> between 2003 and 2011,the volume of pet groups grew 85 fomd. >> thousands of u.s. pets have died. part of the problem is some of our companies are willing to take advantage of china's lax safety measures. >>> when asked if he would buy dog treats from china, solomon towed the fb ix line. >> meanwhile, the fda has not put in place a key part of the food safety modernization act signed into law in 2011. the law says any time the fda identifies a food for people or animals, it must be removed and stores must post a sign at the rej sfer. the

they're selling unapproved fda drugs. drugs the fda has not found safe or drugs that are not even allowed in the u.s. market. >> reporter: often the draw is cheaper prices and claims the drugs are coming from canadian pharmacies which most americans consider safe. >> the drugs that they are shipping to consumers, they believe are coming from canada and have been approved by health canada are really drugs that are coming from places that you would never believe and never suspect. >> reporter: in the fight to stop fakes the fda gets help from pharmaceutical giants like pfizer. they know counterfeits can help the bottom line. john clark says his people found counterfeit versions of 60 different pfizer drugs from last year. that's up to 20 from 2008. >> the better counterfeiters might put in 10, 20 even 30% of the active pharmaceutical ingredient that's supposed to be in the medicine. >> reporter: they test,0 thousas of products a year. it found fake cancer, fake heart, fake cancer drugs and even fake chapstick. >> they will

many are questioning the fda saying it hasn't done enough.a look at what happened in the aftermath of hundreds of pet deaths and illnesses. >> reporter: fewer jerky treats are on the market but it's not enough. lawmakers and fda critics say the agency is failing to warn people about recalled food for both animals and people. daisy brings a welcome puppy happiness to the chambers family after a difficult year. the family dog lost its leader last may. the mix died when her stomach twisted and ruptured. the owner says it happened hours after she ate two milo's kitchen chicken jerky treats. although the cause of her dog's death remains unknown, rachel is one of thousands of pet owners who believe their pet was killed or sickened by tainted treats from china. >> there is something that killed our dog. there's something that killed all those other dogs. >> reporter: the fda received reports of more than 3,200 dogs sickened and 501 deaths, enough to prompt three advisories warning people about chicken and duck jerky treats. the fda has now tested ab

you go to the fda. you have the fda sign off on all of this. why don't you do that?, we do have studies in place--actually, frank-- i mean, we're really excited. we just saw the top line data from a double blind placebo controlled study, which is the gold standard of science. >> after more than four years treating patients, prometa just completed its first double blind study. it's not published yet, but peizer says the results are positive. the study was done by psychiatrist harold urschel. he run a number of drug trials for government and drug companies. but we noticed that while testing prometa, dr. urschel's own addiction clinic was selling prometa among other treatments. this is the gentleman who's supposedly doing the independent research to see if it works. seems like a conflict. >> well, i assure you that there's no conflict. i can't speak to what goes on in his medical building. i have no idea. >> dr. urschel told us he didn't have a financial interest in his clinic's prometa sales, and he sees no conflict. but it's not the first time that prometa has hit que

there is a very unusual and public feud going on at the fda.ue boiledover on the ont page of "the wall street journal" today. according the journal there is disagreement inside the agency over the safety of popular hypertension drugs. some of the drugs may be linked toigher cancer rates. i want to sh folks the drugs that we are talking about. it is vy likely that those who wah the show are actually on these medications are you cn see the brand-name sector. let's lk jusa moment. how do these drugs were? >> they blck sensors from binding to your body. it constricts or narrows blood blood vessels and narrows your blood pressure. >> will this help bring down your blood pressure at the end of the day? that is the simp descriptin of what they do. but what are the dangers that are being reported now? help me understand that remapped. >> this groupof job may w be linked to an interest-rate having cancer. in of particular lung cancer. the person involved in this whtleblowing case, as we call it, they believe that this may increase risk of lungcancer by

the fda basically cutting back because of the sequester cuts leaving people at the fda to administerarket. >> right. a big irony is that a fair amount of the funding for the fda actually comes from the biopharmaceutical industry, companies like mine. tracy: so you pay a fee? >> for them to do their work, and we willingly accept that in order to have a good regulatory process. under the sequester, even the fees that we pay from the private sector into the fda, part of those were sequestered, so congress, fortunately, has a bill right now, i hope it goes through, that's trying to restore that money so that the fda has it available. tracy: trying to reverse everything they did. are you feeling the effects of the sequester yet? >> it's too soon to feel it, but there's no question that the whole industry will be feeling it over the next year or two if something's not done to reverse it. tracy: a total impediment to what you say that we are on the brink of a bunch of great drugs coming to market. >> correct. tracy: thank you for coming on. >> my pleasure, tracy, thanks. ashley: brought you

the fda came back and said o, the magazine is wrong. would he make of that?at is correct and there are only three reasons why the fda is ignoring us. either political, stupidity, or they don't he the manpower to do that or this is not acceptable for any of these reons when it comes to health care. >> i just can't imagine why this is going on. but i have to tell you that the fda and drug approval is not where you wanted to see the agreement of this type. it is either a drug that reduces cancer or it is not a drug that reduces cancer. why can't they answer the question to everybody's satisfaction? >> that is correct. this should be based upon -- not politics or some other types of reoning. we need to figure out what exactly is going on. are they safe for taking these kinds of drugs? gerri: how would this be a political issue do you think it's possible that they arjust trying to keep the indust happy? there a lot of big pharmaceutical copanies in this. >> that's a very good point. gerri: we have a lot more still to ce this hour. a lot more, including some advice

now an fda virusry committee -- advisory committee pored over the data.ontroversies disrupted the lives of diabetics, raised hurdles for testing new drugs and

as the report shows, the fda says the remedy is not without risk. >> the injuries when we push the body hard. >> people basically overdo it. >> 38-year-old12 years of weight lifting left him with crippling shoulder pain. >> eli is not alone. around 2 million mostly middle-aged americans seek medical help for rotator cuff. hundred thousand undergo surgery for ripped ligaments. will eli heard about a non-evasive procedure using stem cells. >> stem cells, its strong anti-inflammatory. >> it's called a b-mac. fluid taken from the bone marrow from the pelvis, spun for 15 minutes, separating the blood from the stem cells which are then injected into the joint where the pain exists. >> within two days, i was stronger i had been in a dozen years. >> the fda and many doctors are still not convinced. >> sometimes these stem cells can form tumors and we certainly don't want to take that risk. >> even though more and more doctors are offering the procedure, it is still not approved by the fda so not widely available. doctors say more testing needs to be done but they acknowledge the future of stem

was micel taylor, mont monsanto former attorney, and now president. >> monsanto captured the fda . this agency, and they are just in the tank with bigusiness? >> month stan to has capture -- monsanto has done the same to many countries they have their people -- >> that makes me sense cal skepf you not them. you look the every scientific authority on subject, whether u.s. national academ of sciences, and world health organization, food and these are all independent bodies of indepeent scientists, every one of those h confirmed that basic safety of biotech food, there has not been a single scientisticly confirmedase of iless or a annaller join. >> since gs have bn introduced a whole news set of diseases and disorders on the rise, these a the what parents doctors say they take them themselv or family off of gmo they get better, but when the take livestock off of the soy or corn, a shift itver, livestock get better, that corn in your hand for emple, does not taste bad to insects it pokes holes in their cells and killing them, new a study, finds that same toxic intensecticide pokes home

was michael taylor, mont monsanto former attorney, and now president. >> monsanto captured the fda . this agency, and they are just in the tank with big business? >> month stan to has capture -- monsanto has done the same to many countries they have tir people - >> that makes me senseal skeptif you not tm. you look the every scientific authority on subject, whether national academy of sciences, and world health organization, food and these are all independent bodies of independent scientists,very one of those has confirmed that basic safety ofiotech food, ere has not been a single scientticl confirmed case of illness or a annaller join. >> since gmos have been introduced a whole news set of diseases and disorders on the rise, these are the what parents andoctors say, they take them themselves or family off of gmo they get better, but when ty take livestock off of the soy or corn, and shift it over, livestock get bette that corn in your hand fo example, does not taste bad to insects it pokes holes in their cells and killing them, new a study, find that same toxic inte insecticide poke

the fda is working to provide priority assistance to manufacturers. we are working on assessing these new ways t. faces two important challenges -- we must adjust the misuse and abuse and addiction that harms our families and communities and the need for appropriate access to pain medication for patients that need them. there can be no doubt there is much to be done and we must act now. these are not simple issues and there are no easy answers. given the complexity of the issue, real and enduring progress will require a multifaceted approach and bind with the dedication, persistence, and engagement of all parties. the fda prioritizes our efforts to combat this outlook health crisis. we welcome the opportunity to work with congress, our partners, the medical community, advocacy organizations, patients and families, to turn the tide on this epidemic. thank you for your interest in this important topic and the opportunity to testify on this issue. i am happy to answer any questions. .> we recognize dr. clark five minutes for an opening statement. good mo

>> well, fda scientists were clear in memos made public from a lawsuit, they said process of genetic engineering is different, and leads to new and defense risks new smyrns newalld toxins, but person in charge of policy at fda was michael taylor, mont monsanto former attorney, and now president. >> monsanto captured the fda . this agency, and they are just in the tank with big business? >> month stan to has capture -- monsanto has done the same to many countries they have their people -- >> that makes me sense cal skepf you not them. you look the every scientific authority on subject, whether u.s. national academy of sciences, and world health organization, food and these are all independent bodies of independent scientists, every one of those has confirmed that basic safety of biotech food, there has not been a single scientisticly confirmed case of illness or a annaller join. >> since gmos have been introduced a whole news set of diseases and disorders on the rise, these are the what parents and doctors say, they take them themselves or family off of gmo they get better, but when t

the fda has said it was not not wanted.t was it should not have been there. there is an investigation and i support an investigation. i do think we have a variety of ways in which you operate in either culture of. it is important to allow choice broadly. that is what we do in the farm bill. that is the right way to go. >> we probably have time for one more question. >> the last question is the next item coming up in the senate. once the farm bill passes, it is full speed ahead to immigration. harry reid says he wants to get the bill done before the july 4 recess. it is my understanding the way the bill came down the last go you actually voted against the final bill. i am curious why that was and why this bill is different. >> i did end up voting against theecause there were not limit on lower wage workers coming into our company that would supplant american jobs. there are many pieces to this. the ad job -- ira culture job -- agriculture jobs east of it is important. i want to congratulate senator feinstein for leading an effort that really brought farmworker

we work with the fda so we can promulgate the increased access to the treatment because that's one of our concerns, making sure people have access to new treatments as they develop and that consumers have access. >> i thank you. i would point out, mr. chairman that i've heard about electronic medical records and the concern are warning that is a broad interpretation and smith versus maryland in which the nsa relies on its current standing with you if you shared your medical records with a third-party insurance company, you would also not required a search warrant to get this record. i don't think that's right, but that's another day. >> the gentleman from pennsylvania, dr. murphy for five minutes for questions. >> thank you, mr. chairman. i appreciate the panel being

are they going to look to the fda? what about the u.s. national security? >> in terms of the process? >> exactly. right now, they have been pretty narrow in terms of military security. we all say food security is national security. is that process going to allow for a broader review of what security is in our country? we want to ask that, urging them to have usda and fda involved in the process. there are a lot of questions. i have not said i am opposed but i have a lots of questions concerns. short-term it may sound great. 10 years down the road, what does this mean for our pork producers? what does it mean for food safety? what are the implications going forward? this is the one area where we have a trade surplus, we are exporting more than we are importing. we have to be thoughtful. >> does the agricultural committee have a role? >> we still can hold meetings and we may. we're going to write letters. we're putting together a list of questions that we're going to to ask those involved to answer. i think it is our job to raise those questions on behalf of

cymbalta is a pain reliever fda-approved to manage chronic musculoskeletal pain. one non-narcotic pill a day, every day, can help reduce this pain. tell your doctor right away if your mood worsens,

field action to the fda because it did not change any of the fda clear labeling and they're workinge fda and sort of urged me not to make too much of this but it is out there. it is something that actually the fda investigator from april to may of this year, worth bringing to your attention, melissa, back to you. >> thank you, herb greenberg. looks like isg is down $7 in the after session. >> let's call it 493. this was a 585 stock. if you need to trade this thing and not saying you have to go plowing in here. you can trade this stock against this 475 low we made a couple times in march and may. i'm surprised, given what herb said, it's not down more. you think intuitive surgical a huge valuation, has to be a monster short interest, maybe not. maybe some people try to get on the back on the short side and maybe push it down. every time it pushed violently. risk reward around 475 might be interesting. >> let's move on to hit our top three trades. xlf ending just under 2% today. karen. >> i think it was a bit of a turnaround frwhere it got crush. when they report three weeks from now,

>> well, fda scientists were clear in memos made public from a lawsuit, they said process of geneticineering is different, and leads to new and defense risks new smyrns newalld toxins, but person in charge of policy at fda was michael taylor, mont monsanto former attorney, and now president. >> monsanto captured the fda . this agency, and they are just in the tank with big business? >> month stan to has capture -- monsanto has done the same to many countries they have their people -- >> that makes me sense cal skepf you not them. you look the every scientific authority on subject, whether u.s. national academy of sciences, and world health organization, food and these are all independent bodies of independent scientists, every one of those has confirmed that basic safety of biotech food, there has not been a single scientisticly confirmed case of illness or a annaller join. >> since gmos have been introduced a whole news set of diseases and disorders on the rise, these are the what parents and doctors say, they take them themselves or family off of gmo they get better, but when they

the fda blocked the cheese from france. a new jersey warehouse, and no one can say how long it will stay there. rich edson is joining us live from the cheese shop in alexandria, virginia. a story? >> reporter: well, we are not talking about this, but it cuts fairly easily. we are talking about this cheese . as you mentioned, the fda has a little bit of an issue with that. they say there are too many cheese mites on the ride which is why they're holding in a warehouse. the fda says basically that we evaluate each sample on the case by case basis. we have a target value of six bytes per square inch. this was established through a survey conducted a number of years ago. now, the owner of this shop poris that that ban, that problem and that standard will be expanded to other cheeses. >> this is what is scary to me as a cheese professional. the mites, that's just one cheese. this is not a huge issue, but some of the most famous cheese is in the world actually have the same situation. and these are ones that people would notice i

the fda is not far behind.king for the e-cigarette companies i may really consider being marketed as a device so you have the opportunity to advertise and people are, i mean it is already, the word-of-mouth has already grown these so far they say by 2023 there will be more vapors, what people who smoke these are called, than smokers. it's a growing, growing business. i think people who use it to quit smoking are the largest percentage of people who use it. melissa: oh, absolutely. seems like everywhere i turn, these things are around. they're especially being advertised a lot. so that is certainly expanding word the mouth. would you advise them to do something like some type of3 disclaimer? like only meant for adults to try to fend off the kid thing out of the gate? >> they're going to have to. melissa, they're part of the 2009 law against tobacco. you can't have flavored tobaccos. the reap for that because they don't want children to be attracted to smoking. these come in flavors. there is water mellon, pena c

now we know the opposite is true and when the fda tried to regulate this because they were worried thathere was no safety record on these large doses of vitamins, they were defeated by a very powerful politically influential industry and ultimately consumers are in a position to know something they don't know. if vitamins were a regulated industry, metavitamins would have a black box warning on them that they can shorten their life. >> why are people going to hear this from you for the first time? >> if we read the medical literature, you wouldn't be hearing it from me for the first time. two studies were a month apart i think and "the wall street journal" had a headline that said is this the end of popping vitamins. in that article there was a quote from the president of gnc corporation where he said we just let these studies pass. this doest affect our business because he knows he's got marketing behind him and he's able to market things as being safe at some level because the fda really isn't responsible for looking over his shoulder. >> when we talk about the vitamins, you say that

mcclure and his team have just told the fda what they have done and the fda has just put out the word safety standards of all of these gadgets, from fetal monitors to defibrillators like this one. make sure that your antivirus software and firewalls are up to date. use biometrics and sophisticated smart cards. make those passwords tougher to figure out. the fda says, so far, it's not aware of any patient injuries or deaths from the hacking of medical equipment. but mcclure says almost everything's wide open. pacemakers and other cardiac equipment can be slowed or disabled, monitors could shut off. at beth israel deaconess medical center in boston a few years ago, a glitch, not a hack, slowed down fetal monitors for women with high-risk pregnancies. the computer systems for these devices are interconnected, wide open and widespread. >> on an average day, beth israel deaconess has 15,000 devices connected to its network, things you wouldn't normally think of as being connected to a network, like a monitor or an iv pump today are smart. >> reporter: dr. john halamka says his hospital doe

we'll tell you what they're targeting and why the fda wants hospitals to come up with a security plan. >>> today marked six months since 20 children and six adults were killed in a shooting rampage at a connecticut elementary school. residents are holding a day of remembrance in newtown to honor those who lost their lives. family members of the victims are expected to attend. police say the gunman 20-year- old adam lanza went to the school after killing his mother at their home. he killed himself as lice arrived at that school. >>> vice president joe biden will be in the bay area later today to attend a democratic fundraiser. he and his wife jill are scheduled to appear at a fundraiser at the san fransisco home of doug hick key at 6:00 tonight. tickets range from 500 to $12,000. they're planning to protest near the event. the visit comes one week after president obama's fund-raising swing through the bay area. >>> the two largest unions of civilian workers in oakland are a step closer to going on strike. members of the unions representing workers who trim trees, drive city trucks and

fda again went back for the last year and looked at this.if we call it the same way, class 4 medication that is not going to have a lot of side-effects or risk people can use it. part of it is because we're desperate. here is diabetes on the growth and we're not producing anything to fight it back. diabetes is costing over $230 billion in this country of health issues and et cetera. so this is a desperate medication that fda had to kind of vote it in. there are always side-effects to all medications. you know it and i know it. just like you remember years ago viagra fairly safe and millions of medications are written about this, a bunch of patients had irish shoes. that is a medication that is fairly similar to that i'm sure it will come out on the market and hopefully will help. arthel: why do they do that? one minute, take this drug and next minute, don't take this drug it will kill you. why do they do that? >> fda leadership before beginning let medications come onto the market and pull them back. once you have a bunch of side-effects bec

fda hasn't really caught up with this. there have been leaks. amount of toxins is want good for you. and the nicotine we have been giving to people, we have been putting it on the patch, the gum, we know how much they are getting. we don't know how much nicotine is going into this and it is inhaling -- it is not really clear. so my vote for this is no. >> i'm not for it either -- >> jamie: limited -- >> i am against it with an asterisk. i am not being political. look, i have a problem with smokers. i have trouble getting them to quit. most of the one who is do do it cold turkey. some, i try to give chantics. but they get anxiety. some i use the nicotine products -- >> but do you recommend this? >> i will get to this. this may be effective short term. the last study looked at 4,000 people in an online questionnaire. i think that's interesting. but it can get out of control. i think it may work, but it's not well regulated. we had people get burned from t. there have been leaks. there is an issue of the toxins. there was one study that showed that

the fda will require chains with 20 or more locations to disclose certain nutrition info by the end of the year. the stock hit a record high yesterday. the numbers are out that detail charitable giving for the past year, and the news is encouraging: up 3.5% to a total amount given of more than $316 billion. it's individuals, not corporations, that do the bulk of the giving, making up almost 80% of all donations. the corporate sector did increase its giving last year by 12.2%. lisa deetlin is a charitable and philanthropic advisor who tells us that giving is a sign of how well the economy is doing. "experts say it is indicative of the economy improving, especially in the corporate sector with corporate donations. that had the largest increase of any of the sectors here with over a 12% increase." lisa also told us that past surveys have shown that more than half of individual donations made come from households with incomes below $100,000. still to come, breaking up is hard to do. stick around for tips on splitting assests that could save your financial future. but first, why more expect

but the fda says there are real risks.ero explains. >> reporter: they're the injuries that come from pushing the body too hard. as we age, those bodies don't as quickly bounce back. >> basically, people overdo it. >> reporter: 32-year-old eli wilhide says 12 years of weightlifting left him with crippling shoulder pain, nothing helped. >> acupuncture, massage, icing. >> reporter: eli is not alone. every year, about 2 million mostly middle-aged americans seek medical help for torn shoulder rotator cuffs. 100,000 undergo surgery on ripped knee ligaments. then eli heard of a new half-hour noninvasive procedure that uses a patient's own stem cells to relieve the pain. >> stem cells, cellular therapy as we call it. it's a strong anti-inflammatory. >> reporter: the procedure is called a bmat. here is how it works -- fluid is taken from the bone marrow of a person's pelvis, spun for 15 minutes, separating the blood from stem cells which are then injected into the joint where the pain exists. >> within two days i was stronger than

that's the word from an appeals court to the fda.want to continue to restrict a newer one-pill formulation which is called plan b one step when i will the fda appeals a ruler court ruling. they okayed the drug for those 15 and older earlier this year. however a judge want it to be available to women of any age. >> you can't find a first dance if you can't have a place to perform that dance. funny the best place for a wedding can be a challenge. >> after that it is smooth sailing but you have to find that place, and it is important. that's why we will go live this morning to downtown baltimore. it is wedding season. what can people expect right now? >> i have been learning a lot this morning, things i didn't know. we are here live in downtown baltimore. this place is amazing. it is really, really nice. elegant, nice rooms. i have only seen just a few of them but very tastefully done. this is one of the hidden gems of the city. i have drew joining me here, and lawrence senior convention services manager here one thing i have learned. w

. >>> and today an fda advisory committee begins a new review of a former blockbuster diabetes drug, deciding whether safety restrictions placed on it in 2010 are too harsh. the fda is taking another look at avandia's heart attack risk now that a recent review found it might not be as dangerous as it once thought. it would be interesting to see how that plays out. >> indeed. ashley morrison here in new york. thank you, ashley. >>> well, coming up on the "morning news," the voice of the boston marathon bombing suspect. audiotaped conversation of the bombing suspect speaking to his mother. this is the "cbs morning news." >> announcer: "moneywatch" sponsored by vagisil wash with odor block. the confident clean. sponsored by vagisil wash with odor block. the confident clean. if yand you're talking toevere rheuyour rheumatologistike me, about trying or adding a biologic. this is humira, adalimumab. this is humira working to help relieve my pain. this is humira helping me through the twists and turns. this is humira helping to protect my joints from further damage. doctors have been prescr

cymbalta is a pain reliever fda-approved to manage chronic musculoskeletal pain. one non-narcotic pill a day, every day, can help reduce this pain. tell your doctor right away if your mood worsens, you have unusual changes in mood or behavior or thoughts of suicide. anti-depressants can increase these in children, teens, and young adults. cymbalta is not for children under 18. people taking maois, linezolid or thioridazine or with uncontrolled glaucoma should not take cymbalta. taking it with nsaid pain relievers, aspirin, or blood thinners may increase bleeding risk. severe liver problems, some fatal, were reported. signs include abdominal pain and yellowing skin or eyes. tell your doctor about all your medicines, including those for migraine and while on cymbalta, call right away if you have high fever, confusion and stiff muscles or serious allergic skin reactions like blisters, peeling rash, hives, or mouth sores to address possible life-threatening conditions. talk about your alcohol use, liver disease and before you reduce or stop cymbalta. dizziness or fain

reporter: we just got a quote from the fda about all of this. the law requires that the fda determine that is reasonable certainty the additive does not cause hammer when useds a intended. the agency continues to monitor food additives and will take appropriate actions. >> shepard: cavuto is next right after this. >> neil: we know the government is tracking our calls. now we're finding out the snooping is wider than anyone thought. >> welcome. i'm in for neil cavuto. this is "your world." can you hear me now? the president says the government is not listening in on phone calls or reading e-mail without a court order but documents are painting a different picture. published reports claiming the nsa collects, processes, and disseminates the content of phone calls and e-mails. the report says the rules allow the nsa to make use of information

mcclure and his team have just told the fda what they have done and the fda has just put out the wordll of these gadgets, from fetal monitors to defibrillators like this one. make sure that your antivirus software and firewalls are up to date. use biometrics and sophisticated smart cards. make those passwords tougher to figure out. the fda says, so far, it's not aware of any patient injuries or deaths from the hacking of medical equipment, but mcclure says almost everything's wide open. pacemakers and other cardiac equipment westbound slowed or disabled. monitors could shut off. at beth israel deaconess medical center in boston a few years ago, a glitch, not a hack, slowed down fetal monitors for women with high-risk pregnancies. the computer systems for these devices are interconnected, wide open, and widespread. >> on an average day, beth israel deaconess has 15,000 devices connected to its network, things you wouldn't normally think of as being connected to a network, like a monitor or an iv pump today are smart. >> dr. john halamka says his hospital does firewall off its system to

i mean, just like anything else that goes before the fda, sometimes it's a crapshoot. now, this was just a phase one trial for both of these, but both look extremely, extremely promising. - good to hear! thanks scott! u.s. wheat faces increased scrutiny from asian countries. japan, taiwan and south korea are all taking measures to ensure no genetically modified or "rogue" wheat comes into those countries. this comes in the wake of modified wheat that has never been approved for human consumption discovered in a farmer's field in oregon. billions of dollars in u.s. food exports are potentially at risk. reuters reports the u.s. has nearly doubled the search team efforts in oregon this week to get to the source of the genetically modified wheat. auto sales are picking up the pace. major u.s. automakers reported in strong numbers for may. the driving force was a continued climb in truck sales. ford and chrysler reported in double-digit gains, while gm sales rose 3.1%, with help from caddilacs, followed by toyota, with 2.5% gain. jim farley, ford's executive vice president

now pet owners have questioned the fda why they haven't found a better way to warn consumers.i, has the law been put in place? >> the food safety modernization act was passed in 2011, part of it requiring stores to post signs at the register about foods that can make people or animals sick or die. there were deaths that could be related to the jerky treats from china. the lawmakers say that they are failing to recognize the danger to the pets, even though they were recalled by the makers. they have issued recalls from wagon train and others, after the discovery of an antibiotic not approved in the u.s. >> you take an 11 1/2 inch piece of paper that could be posted. >> the fda does not have a time line on when they can enact the food safety modernization act. tonight, we'll have more on how a bay area woman is taking part in an upcoming documentary on the pet food industry. >> and if you have a tip for us, give us a call, or send us an e-mail @nbcbayarea.com. [captioning made possible by warner bros. domestic television distribution] captioned by the national captioning institu

the first weight loss drug approved by the fda in 13 years. manufactured by the mountain view company vivas. it's main active ingredient has been used to treat migraines for decades. >> it controls a portion of the brain that's responsible for the feeling of fullness. it makes the stomach feel like it's got enough food in there. >> to counter the potential sedating effects, they combine it with a very low dose of a stimulant. >> it would be 37 milligrams on the market, this has a 3 milligram dose. it's a fraction of what's out there, it doesn't have the agitation or the cardiac effect. i've had one patient that complained of being a little spacy, and she had a high power job, so she stopped it. the majority of patients that i put on this drug have absolutely no side effects. absolutely none at all. >> scott says he's felt no side effects from the drug at all. and he's lost 40 pounds in four months. >> i feel rejuvenated. i'm in a whole new direction. i'm excited for the new direction of life. >> it's interesting, moderately overweight people m

market tuesday, nearly a year after getting approval from the fda. the u.s. drug agency delayed the release on concerns it needs to be listed as a controlled substance because of a low potential for abuse. at the time, belveeq, made by arena, was the first new drug approved by the fda for long-term weightloss in more than a decade. since then, vivus has placed diet drug qsymia on the market. both stocks initially popped on news of the diet drug's approval; however, since then, shares of vivius and arena have been stuck in a trading range. in our cover story, there's a lot buzzing around the specialty coffee industry, which includes coffee roasters, coffee houses and the supply chain that gets it all there. for one thing, it's growing - and according to the specialty coffee association of america, comprises nearly half of all coffee sales in the u.s. the u.s. coffee market is an estimated $30- to $32-billion- a-year industry. cups filled with specialty brews make up 37% of the volume of coffee sold and nearly half of all the money that's made. that's why coffe